Pathogenesis of diabetic neuropathy

Clinical Neuroscience

Volumn 4, Issue 6, 1997, Pages 365-370

  Feldman, Eva L ^a   Stevens, Martin J ^b   Greene, Douglas A ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

Aldose reductase inhibitors; Diabetic neuropathy; Oxidative stress; Polyol pathway

Indexed keywords

AMINO ACID; FREE RADICAL; LIPID; POLYOL; SUPEROXIDE;

DIABETIC NEUROPATHY; HUMAN; HYPERGLYCEMIA; NERVE FIBER TRANSPORT; NEUROTROPISM; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

DIABETIC NEUROPATHIES; FREE RADICAL SCAVENGERS; HUMANS; HYPERGLYCEMIA; NEURAL CONDUCTION; OSMOTIC PRESSURE; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 0030700801     PISSN: 10656766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Bagnasco S, Balaban R, Fales HM, Yang Y-M, Burg M (1986): Predominant osmotically active organic solutes in rat and rabbit renal medullas. J Biol Chem 261:5872-5877.
2. Bagnasco SM, Uchida S, Balaban RS, Kador PF, Burg MB (1987): Induction of aldose reductase and sorbitol in renal inner medullary cells by elevated extracellular NaCl. Proc Natl Acad Sci 84:1718-1720.
3. Bedford JJ, Bagnasco SM, Kador PF, Harris HW Jr, Burg MB (1987): Characterization and purification of a mammalian osmoregulatory protein, aldose reductase, induced in renal medullary cells by high extracellular NaCl. J Biol Chem 262:14255-14259.
4. Bekhor I, Shi S, Carper D, Nishimura C, Unakar NJ (1989): Relative abundance of aldose reductase mRNA in rat lens undergoing development of osmotic cataracts. Curr Eye Res 8:1299-1308.
5. Bondy C, Cowley BD, Lightman SL, Kador PF (1990): Feedback inhibition of aldose reductase gene expression in rat renal medulla. J Clin Invest 86:1103-1108.
6. Burg MB, Garcia-Perez A (1992): How tonicity regulates gene expression. J Am Soc Nephrol 3:121-127.
7. Burg MB, Kador PF (1988): Sorbitol, osmoregulation, and the complications of diabetes. J Clin Invest 81:635-640.
8. Cameron NE, Cotter MA (1993): Potential therapeutic approaches to the treatment or prevention of diabetic neuropathy: Evidence from experimental studies. Diab Med 10:593-605.
9. Cameron NE, Cotter MA, Maxfield EK (1993): Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats. Diabetologia 36:299-304.
10. Cameron NE, Cotter MA, Archibald V, Dines KC, Maxfield EK (1994): Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats. Diabetologia 37:449-459.
11. Carper D, Kaneko M, Stark H, Hohman T (1990): Increase in aldose reductase mRNA in dog lens epithelial cells under Hypertonic conditions. Exp Eye Res 50:743-749.
12. Chesney RW (1985): Taurine: Its biological role and clinical implications. Adv Pediatr 1-42.
13. DelMonte MA, Rabbani R, Diaz TC, Lattimer SA, Nakamura J, Brennan MC, Greene DA (1991): Sorbitol, myo-inositol, and rod outer segment phagocytosis in culture hRPE cells exposed to glucose. Diabetes 40:1335-1345.
14. Diabetes Control and Complications Trial (DCCT) Research Group (1993): The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986.
15. Diabetes Control and Complications Trial (DCCT) Research Group (1995): Effect of intensive diabetes treatment on nerve conduction in the diabetes control and complications trial. Ann Neurol 38:869-880.
16. Dyck PJ, Lais A, Karnes JL, O'Brien P, Rizza R (1986): Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy. Ann Neurol 19:425-439.
17. Gallo G, Pollack ED (1995): Cyclic remodelling of growth cone lamellae and the effect of target tissue. Dev Brain Res 85:140-145.
18. Garcia-Perez A, Burg MB (1991): Role of organic osmolytes in adaptation of renal cells to high osmolality. J Membr Biol 119:1-13.
19. Godin DV, Wohaieb SA, Garnett ME, Gourneniouk AD (1988): Antioxidant enzyme alterations in experimental and clinical diabetes. Mol Cell Biochem 84:223-231.
20. Greene DA, Lattimer SA (1982): Sodium-and energy-dependent uptake of myo-inositol by rabbit peripheral nerve. J Clin Invest 70:1009-1018.
21. Greene DA, Lattimer SA (1983): Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation. J Clin Invest 72:1058-1063.
22. Greene DA, Sima AAF, Stevens MJ, Feldman EL, Lattimer SA (1992): Complications: Neuropathy, pathogenetic considerations. Diabetes Care 15:1902-1925.
23. Greene DA, Sima AAF, Stevens MJ, Feldman EL, Killen PD, Henry DN, Thomas T, Dananberg J, Lattimer SA (1993): Aldose reductase inhibitors: An approach to the treatment of diabetic nerve damage. Diabetes/Metab Rev 9:189-217.
24. Gullans SR, Verbalis JG (1993): Control of brain volume during hyperosmolar and hypoosmolar conditions. Ann Rev Med 44:289-301.
25. Henry DN, Del Monte M, Greene DA, Killen PD (1993): Altered aldose reductase gene regulation in cultured human retinal pigment epithelial cells. J Clin Invest 92:617-623.
26. Herman WH, Sinnock P, Brenner E, Brimberry JL, Langford D, Nakashima A, Sepe SJ, Teutsch SM, Mazze RS (1984): An epidemiologic model for diabetes mellitus: Incidence, prevalence, and mortality. Diabetes Care 7:367-371.
27. Jennings PE, Jones AF, Florkowski CM, Lunec J, Barnett AH (1987): Increased diene conjugates in diabetic subjects with microangiopathy. Diab Med 4:452-456.
28. Johnson PC, Doll SC, Cromey DW (1986): Pathogenesis of diabetic neuropathy. Ann Neurol 19:450-157.
29. 1 cells: Role of protein synthesis and protein kinase C activation. J Amer Soc Nephrol 2:1021-1029.
30. Kaneko M, Carper D, Nishimura C, Millen J, Bock M, Hohman TC (1990): Induction of aldose reductase expression in rat kidney mesangial cells and chinese hamster ovary cells under hypertonic conditions. Exp Cell Res 188:135-140.
31. Kumar JS, Menon VP (1992): Peroxidative changes in experimental diabetes mellitus. Indian J Med Res 96:176-181.
32. Kwon HM, Yamauchi A, Uchida S, Robey B, Garcia-Perez A, Burg MB, Handler JS (1991): Renal Na-myo-inositol cotransporter mRNA expression in Xenopus oocytes: Regulation by hypertonicity. Am J Physiol 260:F258-F263.
33. Laron Z, Anin S, Klipper-Aurbach Y, Klinger B (1992): Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism. Lancet 339:1258-1261.
34. Loven D, Schedl H, Wilson H, Daabees TT, Stegink LD, Diekus M, Oberley L (1986): Effect of insulin and oral glutathione on glutathione levels and superoxide dismutase activities in organs of rats with streptozotocin-induced diabetes. Diabetes 35:503-507.
35. Loven DP, Schedl HP, Oberley LW, Wilson HD, Bruch L, Niehaus CL (1982): Superoxide dismutase activity in the intestine of the streptozotocin-diabetic rat. Endocrinology 111:737-742.
36. Low PA, Nickander KK (1991): Oxygen free radical effects in sciatic nerve in experimental diabetes. Diabetes 40:873-877.
37. Low PA, Tuck RR, Takeuchi M (1987): Nerve microenvironment in diabetic neuropathy. Dyck PJ, Thomas PK, Winegrad AI, Porte D., eds. In Diabetic Neuropathy. Philadelphia: Saunders, pp 266-278.
38. Matkovics B, Varga SI, Szabo L, Witas H (1982): The effect of diabetes on the activities of the peroxide metabolism enzymes. Horm Metab Res 14:77-79.
39. Morales HP, Schousboe A (1988): Volume regulation in astrocytes: A role for taurine as an osmoeffector. J Neurosci Res 20:505-509.
40. Mukherjee B, Mukherjee JR, Chatterjee M (1994): Lipid peroxidation, glutathione levels and changes in glutathione-related enzyme activities in streptozotocin-induced diabetic rats. Immunol Cell Biol 72:109-114.
41. Nakamura J, Del Monte MA, Shewach D, Lattimer SA, Greene DA (1992): Inhibition of phosphatidylinositol synthase by glucose in human retinal pigment epithelial cells. Am J Physiol: Endocrinol Metab 262:E417-E426.
42. Nakanishi T, Burg MB (1989): Osmoregulatory fluxes of myo-inositol and betaine in renal cells. Am J Physiol 257:C964-C970.
43. Ohtaka M, Tawata M, Hosaka Y, Onaya T (1992): Glucose modulation of aldose reductase mRNA expression and its activity in cultured calf pulmonary artery endothelial cells. Diabetologia 35:730-734.
44. Oja SS, Kontro P (1990): Neuromodulatory and trophic actions of taurine. In Taurine: Functional Neurochemistry, Physiology and Cardiology. Wiley-Liss, Inc., pp 1-20.
45. Pirart J (1978): Diabetes mellitus and its degenerative complications; A prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1:168-188.
46. Sima AAF, Stevens MJ, Feldman EL, Cherian PV, Greene DA (1993): Animal models as tools for the testing of preventive and therapeutic measures in diabetic neuropathy. In Shafrir E (eds): Lessons From Animal Diabetes IV. Great Britain: Smith-Gordon, pp 177-191.
47. Smardo FL, Burg MB, Garcia-Perez A (1992): Kidney aldose reductase gene transcription is osmotically regulated. Am J Physiol Cell Physiol 262:C776-C782.
48. Stevens JJ, Lattimer SA, Kamijo M, VanHuysen C, Sima AAF, Greene DA (1993): Osmotically-induced nerve taurine depletion and the compatible osmolyte hypothesis in experimental diabetic neuropathy in the rat. Diabetologia 36:608-614.
49. Stevens MJ (1995): Nitric oxide as a potential bridge between the metabolic and vascular hypotheses of diabetic neuropathy. Diab Med 12:292-295.
50. +)-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. J Clin Invest 94:853-859.
51. Strange K, Morrison R, Heilig CW, DiPietro S, Gullans SR (1991): Upregulation of inositol transport mediates inositol accumulation in hyperosmolar brain cells. Am J Physiol: Cell Physiol 260:C784-C790.
52. Tagami S, Kondo T, Yoshida K, Hirokawa J, Ohtsuka Y, Kawakami Y (1992): Effect of insulin on impaired antioxidant activities in aortic endothelial cells from diabetic rabbits. Metabolism 41:1053-1058.
53. Thomas TP, Feldman EL, Nakamura J, Kato K, Lien M, Stevens MJ, Greene DA (1993): Ambient glucose and aldose reductase-induced myo-inositol depletion modulate basal and carbachol-stimulated inositol phospholipid metabolism and diacylglycerol accumulation in human retinal pigment epithelial cells in culture. Proc Natl Acad Sci USA 90:9712-9716.
54. Tuck RR, Schmelzer JD, Low PA (1984): Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 107:935-950.
55. Uchida S, Nakanishi T, Kwon HM, Preston AS, Handler JS (1991): Taurine behaves as an osmolyte in madin-darby canine kidney cells. J Clin Invest 88:656-662.
56. Uzel N, Sivas A, Uysal M, Oz H (1987): Erythrocyte lipid peroxidation and glutathione peroxidase activities in patients with diabetes mellitus. Horm Metab Res 19:89-90.
57. van Dam PS, Van Asbeck BS, Erkelens DW, Marx JJ, Gispen WH, Bravenboer B (1995): The role of oxidative stress in neuropathy and other diabetic complications. Diabetes/Metabol Rev 11:181-192.
58. Williams E, Timperley WR, Ward JD, Duckworth T (1980): Electron microscopical studies of vessels in diabetic peripheral neuropathy. J Clin Pathol 33:462-470.
59. Wohaieb SA, Godin DV (1987): Alterations in free radical tissue-defense mechanisms in streptozotocin-induced diabetes in rats. Diabetes 36:1014-1018.
60. Yancey PH, Clark ME, Hand SC, Bowlus RD, Somero GN (1982): Living with water stress: Evolution of osmolyte systems. Science 217:1214-1222.